Considerations for Optimal Management of Patients With Pulmonary Arterial Hypertension: A Multi-Stak

Considerations for Optimal Management of Patients With Pulmonary Arterial Hypertension: A Multi-Stakeholder Roundtable Discussion

BySean M. Studer, MD, MSc,Martha Kingman, FNP-C,DNP,Luis Calo, MD, MMM, FAAFP,H. Eric Cannon, PharmD, FAMCP,Jeffrey D. Dunn, PharmD, MBA,Thomas James III, MD,Sonya J. Lewis, PharmD, MBA,Robert J

May 19th 2017

Stakeholders, including national and regional managed care decision makers and providers, met to discuss the clinical background, health economics, and management strategies for pulmonary arterial hypertension (PAH) at a roundtable meeting on December 10, 2016, in Dallas, Texas.

Participating Faculty

May 19th 2017

Considerations for Optimal Management of Patients With Pulmonary Arterial Hypertension: A Multi-Stak

Considerations for Optimal Management of Patients With Pulmonary Arterial Hypertension: A Multi-Stakeholder Roundtable Discussion

Participating Faculty

Trending on AJMC

Reduction in Food Allergies Found After Guideline-Directed Early Peanut Exposure

FDA Expands Semaglutide Label to Reduce Cardiovascular Risk in Adults With Type 2 Diabetes

Adding Radioligand Therapy Pluvicto to SOC Cuts Risk of Prostate Cancer Progression or Death 28%, but How Many Doses?

KEYNOTE-905 Paves the Way for Next Generation of MIBC Trials: Christof Vulsteke, MD, PhD

Shifts in Colorectal Cancer Screening Trends After COVID-19